Adrenocorticotropin/alpha-melanocyte-stimulating hormone (ACTH/MSH)-like peptides modulate adenylate cyclase activity in rat brain slices: evidence for an ACTH/MSH receptor-coupled mechanism

J Neurochem. 1993 Jun;60(6):2204-11. doi: 10.1111/j.1471-4159.1993.tb03506.x.

Abstract

The regulation of adenylate cyclase activity by adrenocorticotropin/alpha-melanocyte-stimulating hormone (ACTH/MSH)-like peptides was investigated in rat brain slices using a superfusion method. Adenylate cyclase activity was concentration-dependently increased by ACTH-(1-24), alpha-MSH (EC50 values 16 and 6 nM, respectively), and [Nle4,D-Phe7]alpha-MSH (EC50 value 1.6 nM), in the presence of forskolin (1 microM, optimal concentration). 1-9-Dideoxyforskolin did not augment the response of adenylate cyclase to ACTH-(1-24). Various peptide fragments were tested for their ability to enhance [3H]cyclic AMP production. [Nle4,D-Phe7]alpha-MSH increased [3H]cyclic AMP formation with a maximal effect of 30% and was more potent than ACTH-(1-24), ACTH-(1-16)-NH2, alpha-MSH, ACTH-(1-13)-NH2, [MetO4]alpha-MSH, [MetO2(4),D-Lys8,Phe9]ACTH-(4-9), ACTH-(7-16)-NH2, ACTH-(1-10), and ACTH-(11-24), in order of potency. This structure-activity relationship resembles that found for the previously described peptide-induced display of excessive grooming. ACTH-(1-24) stimulated adenylate cyclase activity in both striatal (maximal effect, approximately 20%) and septal slices (maximal effect, approximately 40%), but not in hippocampal or cortical slices. Lesioning of the dopaminergic projections to the striatum did not result in a diminished effect of [Nle4,D-Phe7]alpha-MSH on [3H]cyclic AMP accumulation, which indicates that the ACTH/MSH receptor-stimulated adenylate cyclase is not located on striatal dopaminergic terminals. ACTH-(1-24) did not affect the dopamine D1 or D2 receptor-mediated modulation of adenylate cyclase activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / pharmacology
  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Adenylyl Cyclases / metabolism*
  • Adrenocorticotropic Hormone / analogs & derivatives*
  • Adrenocorticotropic Hormone / pharmacology*
  • Animals
  • Brain / drug effects
  • Brain / enzymology*
  • Brain / metabolism
  • Chromatography, High Pressure Liquid
  • Colforsin / analogs & derivatives
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism
  • Desipramine / pharmacology
  • Dopamine / metabolism
  • Dopamine / pharmacology
  • Dose-Response Relationship, Drug
  • Ergolines / pharmacology
  • In Vitro Techniques
  • Kinetics
  • Male
  • Organ Specificity
  • Oxidopamine / toxicity
  • Quinpirole
  • Rats
  • Rats, Wistar
  • Receptors, Corticotropin
  • Receptors, Pituitary Hormone / drug effects
  • Receptors, Pituitary Hormone / physiology*
  • Sulpiride / pharmacology
  • alpha-MSH / pharmacology*

Substances

  • Ergolines
  • Receptors, Corticotropin
  • Receptors, Pituitary Hormone
  • 3,4-Dihydroxyphenylacetic Acid
  • Colforsin
  • Quinpirole
  • alpha-MSH
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Sulpiride
  • MSH receptor
  • Oxidopamine
  • Adrenocorticotropic Hormone
  • Cyclic AMP
  • Adenylyl Cyclases
  • Desipramine
  • Dopamine